News for Joinn Laboratories (China) Co.,Ltd. (603127.SS)

Published at

Jul 21, 2023 3:20 PM

by benzinga.com

positive

positive

Joinn Profits Slide As Lab Monkey Build-up Backfires

Key Takeaways: Joinn Lab is heading for a loss in the second quarter, weighing on its profit performance for the half year, as the market value of its lab monkeys tumbled Many of its investors have sold off blocks of shares since last April By Molly Wen

6127.HK 603127.SS

Read more →
Published at

Jul 21, 2023 8:17 AM

by seekingalpha.com

positive

positive

Joinn Profits Slide As Lab Monkey Build-Up Backfires

The leading provider of pre-clinical drug research has predicted its first-half profits will plummet between 70% and 80% due to the falling value of its lab animals.

6127.HK 603127.SS

Read more →
Published at

Jun 21, 2023 4:59 PM

by benzinga.com

mixed

mixed

Cash-strapped Viva Biotech Sells Stake And Plans Spinoff

Key Takeaways： As well as tapping strategic investors, Viva Biotech is planning to list its drug research subsidiary on a Chinese exchange by the end of 2026 A sinking share price has piled pressure on the company to buy back its convertible bonds, hence the need for funds By Molly Wen

VBIZF 6127.HK 603127.SS 1873.HK

Read more →
Published at

Jun 21, 2023 12:40 PM

by seekingalpha.com

mixed

mixed

Cash-Strapped Viva Biotech Sells Stake And Plans Spinoff

As well as tapping strategic investors, Viva Biotech is planning to list its drug research subsidiary on a Chinese exchange by the end of 2026.

6127.HK 603127.SS VBIZF 1873.HK

Read more →
Published at

Oct 25, 2022 9:42 AM

by seekingalpha.com

positive

positive

Joinn Lab Posts Bumper Profit Despite Covid Disruptions

Joinn Lab’s net profit in the first three quarters of this year surpassed the figure for all 2021 as the company rapidly expanded its capacity.

6127.HK 603127.SS

Read more →
Published at

Oct 24, 2022 5:52 PM

by benzinga.com

positive

positive

What Pandemic? Joinn Lab Posts Bumper Profit Despite Covid Disruptions

Key Takeaways: Joinn Lab’s net profit in the first three quarters of this year surpassed the figure for all 2021 as the company rapidly expanded its capacity The company is strongly positioned due to high barriers to entry, and a broad presence in its industry chain through its acquisition of lab animal suppliers

6127.HK 603127.SS

Read more →

News for Joinn Laboratories (China) Co.,Ltd. (603127.SS)

Joinn Profits Slide As Lab Monkey Build-up Backfires

Joinn Profits Slide As Lab Monkey Build-Up Backfires

Cash-strapped Viva Biotech Sells Stake And Plans Spinoff

Cash-Strapped Viva Biotech Sells Stake And Plans Spinoff

Joinn Lab Posts Bumper Profit Despite Covid Disruptions

What Pandemic? Joinn Lab Posts Bumper Profit Despite Covid Disruptions